borderline significantp = 0.05
Nerinetide showed a borderline significant mortality reduction versus placebo (RR = 0.86; 95% CI 0.75–1.00; p = 0.05) with low heterogeneity ( I 2 = 11%).
Nerinetide showed a borderline significant mortality reduction versus placebo (RR = 0.86; 95% CI 0.75–1.00; p = 0.05) with low heterogeneity ( I 2 = 11%).
Among them, atrial fibrillation showed a positive association with the risk of death (coefficient = 0.0142; p = 0.0489), while any past stroke also demonstrated a positive and marginally significant association (coefficient = 0.0259; p = 0.0519).
Although this difference did not reach statistical significance, the trend warrants attention.